Predictors of Retinochoroiditis in Children With Congenital Toxoplasmosis: European, Prospective Cohort Study
Authors:
- Ruth GilbertRGRuth Gilbert
- for the European Multicentre Study on Congenital ToxoplasmosisFTfor the European Multicentre Study on Congenital Toxoplasmosis
- 1 May 2008
- journal article
- research article
- Published by American Academy of Pediatrics (AAP) in Pediatrics
- Vol. 121 (5) , e1215-e1222
Abstract
OBJECTIVE. By school age, 20% of children infected with congenital toxoplasmosis will have ≥1 retinochoroidal lesion. We determined which children are most at risk and whether prenatal treatment reduces the risk of retinochoroiditis to help clinicians decide about treatment and follow-up. PATIENTS AND METHODS. We prospectively studied a cohort of children with congenital toxoplasmosis identified by prenatal or neonatal screening in 6 European countries. We determined the effects of prenatal treatment and prognostic markers soon after birth on the age at first detection of retinochoroiditis. RESULTS. Of 281 children with congenital toxoplasmosis, 50 developed ocular disease, and 17 had recurrent retinochoroiditis during a median follow-up of 4.1 years. Prenatal treatment had no significant effect on the age at first or subsequent lesions. Delayed start of postnatal treatment did not increase retinochoroiditis, but the analysis lacked power. Older gestational age at maternal seroconversion was weakly associated with a reduced risk of retinochoroiditis. The presence of nonocular clinical manifestations of congenital toxoplasmosis at birth strongly predicted retinochoroiditis. For 92% (230 of 249) of children with no retinochoroiditis detected before 4 months of age, the probability of retinochoroiditis by 4 years was low, whether clinical manifestations were present or not 8.0%. CONCLUSIONS. Prenatal treatment did not significantly reduce the risk of retinochoroiditis in this European cohort. If children have no retinochoroiditis in early infancy, the low risk of subsequent ocular disease may not justify postnatal treatment and repeated ophthalmic assessments during childhood. Controlled trials are needed to address the lack of evidence for the effectiveness of postnatal treatment.Keywords
This publication has 16 references indexed in Scilit:
- Risk of Visual Impairment in Children with Congenital Toxoplasmic RetinochoroiditisAmerican Journal of Ophthalmology, 2007
- Newborn screening for congenital toxoplasmosis: feasible, but benefits are not establishedArchives of Disease in Childhood, 2006
- Globalization and the population structure of Toxoplasma gondiiProceedings of the National Academy of Sciences, 2006
- Association between prenatal treatment and clinical manifestations of congenital toxoplasmosis in infancy: A cohort study in 13 European centresActa Paediatrica, 2005
- Prediction of congenital toxoplasmosis by polymerase chain reaction analysis of amniotic fluidBJOG: An International Journal of Obstetrics & Gynaecology, 2005
- Genetic diversity, clonality and sexuality in Toxoplasma gondiiInternational Journal for Parasitology, 2004
- Effect of timing and type of treatment on the risk of mother to child transmission of Toxoplasma gondiiBJOG: An International Journal of Obstetrics & Gynaecology, 2003
- Antibiotics versus control for toxoplasma retinochoroiditis2002
- Multiple Events per Subject2000
- Feasibility of neonatal screening for toxoplasma infection in the absence of prenatal treatmentThe Lancet, 1999